After establishing marketing in Europe and the Middle East, Stentys has announced it is continuing its international development by establishing partnerships with national distributors specialised in cardiovascular products in Singapore, Hong Kong and Malaysia. This expansion is part of the company’s strategy to promote its stent in countries that represent significant potential for the Self-Apposing stent and recognise the CE mark.
Gonzague Issenmann, chief executive officer and co-founder of Stentys, commented: “Stentys’ sales expansion through national distributors in the Middle East was a substantial success in 2013, and we plan to replicate this model across Asia. The excellent feedback we have received from opinion leaders in this new region makes us confident that our stent will be rapidly adopted in Southeast Asia.”
